Dr. Jake Becraft is the Co-Founder and Chief Executive Officer of Strand Therapeutics, a biotechnology company pioneering programmable mRNA medicines. With a PhD in Biological Engineering from MIT, Dr. Becraft has led the development of gene circuit technologies that transform how cells can be programmed to sense, compute, and respond within the body.

Under his leadership, Strand has advanced next-generation mRNA therapies into clinical development and built one of the world’s most sophisticated synthetic biology platforms. Dr. Becraft’s work sits at the intersection of biotechnology, national security, and public policy, focusing on how innovation can strengthen both health systems and global resilience.

He is widely recognized as a thought leader in emerging biotechnology, has received numerous national awards for scientific and entrepreneurial excellence, and is a passionate advocate for responsible technology development, collaboration, and trust between science and society.